News
Verizon currently offers a 6.4% dividend yield, and its cash flow is steady. Chevron has raised its dividend every year for ...
The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...
9h
VISTA.Today on MSNMerck Expands Biomanufacturing with Staggering Investment in WilmingtonMerck, the Pharma giant with operations in Lansdale, announced on Tuesday that it will build a $1 billion “biologics center ...
22h
Medpage Today on MSNOncologists Dish on Insurers; 'Torrent of Hate' After Diagnosis; More Risky TanningMore than 80% of oncologists participating in a global survey consider insurance a major barrier to timely cancer care.
Sales of the company’s copycat to J&J’s blockbuster medicine reached $150 million in the first quarter, adding to a surge in ...
The drugmaker remains convinced of the potential of the drug, however, and has just reported results of a trial comparing Jemperli (dostarlimab) to Merck & Co's market-leading Keytruda ...
The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results